3D Global Biotech Inc.
6808
Rank in Stocks
#21906
Based in New Taipei City, China, 3D Global Biotech Inc. (3DGBI) specializes in... Based in New Taipei City, China, 3D Global Biotech Inc. (3DGBI) specializes in the development of advanced medical materials designed for human body reconstruction. The company leverages sophisticated cell culture systems, cutting-edge 3D printing technology, and proprietary bio-inks hydrogel to create personalized, patient-specific cell-based medical products. Beyond product manufacturing, 3DGBI is dedicated to building platforms for human tissue and organ regeneration, engineering customized medical equipment, and undertaking significant professional research. Its extensive product range includes artificial bone substitutes, skull fixation systems, biological dressings, bio-inks, and bioprinting machinery. They also offer specialized solutions for orthopedic, dental, cranial, and scalp reconstruction. The company serves a broad spectrum of clients, including medical centers, research institutions, businesses, and distributors. 3DGBI actively fosters an interdisciplinary alliance, bringing together expertise from industry, government, academia, research, and medicine. It was established in 2014.
Share Price
$0.79259593
Last synced: 2026-11-10
Market Cap
$61.02M
Change (1 day)
0.00%
Change (1 year)
-47.06%
Country
Stock data: Financial Modeling PrepΒ·Updated Β·Not investment adviceΒ·How we calculate this
Trade 3D Global Biotech Inc. (6808)
Category
Healthcare
EPS for 3D Global Biotech Inc. (6808)
EPS as of June 2026 TTM: $0.01
According to 3D Global Biotech Inc.'s latest financial reports, its current EPS (TTM) is $0.01. At the end of 2025 the company had an EPS of $0.03, a decrease compared to its 2024 EPS of $0.04.
EPS history for 3D Global Biotech Inc. from 2017 to 2026
EPS at the end of each year
| Year | EPS | Change |
|---|---|---|
| 2026 (TTM) | $0.01 | -80.33% |
| 2025 | $0.03 | -32.35% |
| 2024 | $0.04 | -220.54% |
| 2023 | $-0.03 | -15.58% |
| 2022 | $-0.04 | -0.50% |
| 2021 | $-0.04 | 26.18% |
| 2020 | $-0.03 | 31.54% |
| 2019 | $-0.02 | -8.02% |
| 2018 | $-0.03 | 7.82% |
| 2017 | $-0.02 | 0.00% |
EPS for similar companies or competitors
| Company | EPS | EPS Difference | Country |
|---|---|---|---|
| $15.66 | 265,323.73% |
US
|
|
| $-7.07 | -119,930.51% |
US
|
|
| $-5.29 | -89,761.02% |
AU
|
|
| $12.88 | 218,206.78% |
BE
|
|
| $21.56 | 365,323.73% |
NL
|
Questions about 3D Global Biotech Inc.'s earnings per share (EPS)
What is 3D Global Biotech Inc.'s earnings per share (EPS)?
3D Global Biotech Inc.'s earnings per share (EPS) over the last twelve months is $0.01, as of Jun 2026.
What was 3D Global Biotech Inc.'s earnings per share (EPS) in 2025?
In 2025, 3D Global Biotech Inc.'s earnings per share (EPS) was $0.03, 25.00% less than in 2024 ($0.04).
How has 3D Global Biotech Inc.'s earnings per share (EPS) changed since 2020?
From 2020 to 2025, 3D Global Biotech Inc.'s earnings per share (EPS) was highest in 2024 ($0.04) and lowest in 2022 ($-0.04).
How does 3D Global Biotech Inc.'s earnings per share (EPS) compare with similar companies?
3D Global Biotech Inc.'s earnings per share (EPS) ($0.01) is higher than that of 2 of the 5 similar companies listed above. The highest among them is Argenx SE, with $21.56.